Rajeev Shah's most recent trade in Black Diamond Therapeutics Inc was a trade of 16,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 16, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics Inc | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics Inc | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics Inc | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Kala Pharma Inc | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Rajeev Shah | Director, Ten Percent Owner | 16 Jun 2021 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | ||
| Black Diamond Therapeutics Inc | Rajeev Shah | Director | Other type of transaction at price $ 24.01 per share. | 20 May 2021 | 443 | 0 (0%) | 0% | 24.0 | 10,636 | Common Stock |
| Black Diamond Therapeutics Inc | Rajeev Shah | Director | Other type of transaction at price $ 24.26 per share. | 01 Apr 2021 | 353,814 | 2,277,978 (6%) | 0% | 24.3 | 8,583,528 | Common Stock |
| Black Diamond Therapeutics Inc | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 24.01 per share. | 18 Mar 2021 | 443 | 443 (0%) | 0% | 24.0 | 10,636 | Common Stock |